[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$rhhby

Roche's breast cancer drug Itovebi receives EU approval, boosting engagements, but US regulatory hurdles create uncertainty. The company is also making moves into direct-to-customer sales, which could be a new growth area.

About $rhhby

Financial analysis of Roche (RHHBY), focusing on market sentiment, clinical trial results, and regulatory approvals.

Insights #

$rhhby sentiment is up XXXXX% from the previous week.
$rhhby creators is up XXXXX% from the previous week.
$rhhby engagements is up XXXXX% from the previous week.
$rhhby mentions is up XXXXX% from the previous year.
$rhhby posts created is up XX% from the previous year.

Engagements: XXXXXX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Week: XXXXXXX +70%
1 Month: XXXXXXX +7%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXX +21%
1-Year High: XXXXXXX on 2024-12-05
1-Year Low: XXX on 2025-07-27

Social Network	X	Reddit
Engagements	XXXXXX	X

Mentions: XXX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XX
1 Week: XXX +52%
1 Month: XXX +63%
6 Months: XXXXX +22%
1 Year: XXXXX +91%
1-Year High: XXX on 2024-11-17
1-Year Low: XX on 2025-01-27

Social Network	X	Reddit
Mentions	XXX	X

Creators: XX #

Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning $rhhby in the last XX hours which is down XXXX% from XX in the previous XX hours Daily Average: XX
1 Week: XX +17%
1 Month: XXX -XX%
6 Months: XXX +17%
1 Year: XXXXX +126%
1-Year High: XXX on 2024-12-03
1-Year Low: XX on 2025-01-27

The most influential creators that mention $rhhby in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@BiopharmIQ	X	XXXXXX	X	XXXXX
@AponiaAnalytics	X	XXXXX	XX	XXXXX
@Quantumup1	X	XXXXX	X	XXXXX

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +8%
1 Month: XX% -XX%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-10-18
1-Year Low: XX% on 2024-12-22

Most Supportive Themes

Positive Clinical Data and Regulatory Approvals: (47%) Positive clinical trial results and regulatory approvals are generating positive sentiment.
Strategic Investments and Collaborations: (24%) Roche's strategic investments and collaborations signal growth and innovation.
Dividend Aristocrat Status: (9%) Roche's financial stability is highlighted by its inclusion in lists of international dividend aristocrats.

Most Critical Themes

Columvi Expansion Faces US Regulatory Hurdles: (2.2%) Potential regulatory hurdles for Columvi expansion in the US may impact financial performance.
Drug Pricing Pressures: (1.8%) The reimplementation of the drug pricing order may impact large-cap drugmakers.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXXXX	XX%	XXXXX	XX%	XXXXX	XX%
Reddit	X	X%	X	X%	X	X%

Total	XXXXX	XX%	XXXXX	XX%	XXXXX	XX%

Top assets mentioned In the posts about $rhhby in the last XX hours

Hims & Hers Health, Inc. (HIMS) GSK plc (GSK) Eli Lilly and Company (LLY) Regeneron Pharmaceuticals Inc (REGN) Synthetify (SNY) Bitcoin Incognito (XBI) Gilead Sciences, Inc. (GILD) Sarepta Therapeutics, Inc. (SRPT) Novartis AG (NVS) Merck & Co., Inc. (MRK)

Top topics mentioned In the posts about $rhhby in the last XX hours

manat, sny, $hims, $vani, hims, $zldpf, pfe, $gsk, $lly, amgn, stocks healthcare, $regn, abbv, acquisition, $sny, $xbi, $gild, stocks, $sgmo, nvda, stockmarket, jacob, sarepta therapeutics inc, $asnd, $zeal, drugs, $nvs, $bgne, weight loss, $kalv, $repl, $1b, jnj, $mrk, ce, djt, $8b, $biib, $srpt, investment, eli lilly, $pph, $xph, $ibb, $abvx, onc, sarepta therapeutics, bloomberg, amzn, $27b, repl, dis, meta, googl, goog, realdonaldtrump, $vrtx, $gmab, $rog, tak, blk, approved, $vtrs, spy, $rcus, $nbix, $srzn, $eypt, soundcloud, $tak, $jnj, $rhhbf, gibraltar pound, $nwbo, $bmy, $33m, xr, regeneron pharmaceuticals inc, $actu, $rut, $kzia, $tptx, $gbt, $dsnky, primary market, $650m, money, $srpts, japan, $1035m, cfr, bfb, evo, $edit, h2, $vktx, $vik, op, rbc, combo